It was clearly observed that tumor volume and weight were conspicuously decreased after niraparib injection compared with injection of PBS, whereas MEG3 silencing could retarded niraparib-mediated tumor inhibition (Figs. 7A–7C). This evidence concerns the gene MEG3 and neoplasm.